Published in J Allergy Clin Immunol on September 13, 2012
Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy. Thorax (2014) 1.52
Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Am J Respir Crit Care Med (2014) 1.23
Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol (2012) 1.09
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol (2015) 1.00
Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators Inflamm (2015) 0.97
Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons. J Allergy Clin Immunol (2015) 0.96
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerg Microbes Infect (2014) 0.96
Interleukin-1 receptor-associated kinase M (IRAK-M) promotes human rhinovirus infection in lung epithelial cells via the autophagic pathway. Virology (2013) 0.95
Virus/allergen interactions in asthma. Curr Allergy Asthma Rep (2013) 0.93
Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations. J Leukoc Biol (2014) 0.92
Cytokine production and signaling pathways in respiratory virus infection. Front Microbiol (2013) 0.88
Early-life viral infections and the development of asthma: a target for asthma prevention? Curr Opin Allergy Clin Immunol (2014) 0.86
Impact of air pollution on respiratory diseases in children with recurrent wheezing or asthma. BMC Pulm Med (2014) 0.84
Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. J Allergy Clin Immunol (2014) 0.83
Response of airway epithelial cells to double-stranded RNA in an allergic environment. Transl Respir Med (2014) 0.78
1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (EC-18) Modulates Th2 Immunity through Attenuation of IL-4 Expression. Immune Netw (2015) 0.78
Rhinovirus and childhood asthma: an update. Korean J Pediatr (2016) 0.77
Understanding the Association of Human Rhinovirus with Asthma. Clin Vaccine Immunol (2015) 0.77
Rhinovirus-induced asthma exacerbations during childhood: the importance of understanding the atopic status of the host. J Allergy Clin Immunol (2012) 0.77
Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond. Allergy Asthma Immunol Res (2015) 0.77
Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis. Clin Exp Immunol (2016) 0.77
The influence of atopy and asthma on immune responses in inner-city adults. Immun Inflamm Dis (2016) 0.76
IFN Deficiency in Asthma Attacks. Is Restoring Toll-like Receptor-7 Expression a New Treatment Approach in Severe Asthma? Am J Respir Crit Care Med (2016) 0.75
Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium. J Antimicrob Chemother (2016) 0.75
Rhinovirus species and clinical characteristics in the first wheezing episode in children. J Med Virol (2016) 0.75
Recent advances in understanding and managing asthma. F1000Res (2016) 0.75
Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity. Curr Respir Med Rev (2014) 0.75
Early local immune defences in the respiratory tract. Nat Rev Immunol (2016) 0.75
Medical and Social Determinants of Health Associated with Intensive Care Admission for Asthma in Children. Ann Am Thorac Soc (2016) 0.75
Rhinovirus-Induced Airway Disease: A Model to Understand the Antiviral and Th2 Epithelial Immune Dysregulation in Childhood Asthma. J Investig Med (2015) 0.75
Respiratory viral infections and host responses; insights from genomics. Respir Res (2016) 0.75
Treatment of Severe Acute Asthma is Damage Control. J Pediatr Pharmacol Ther (2013) 0.75
Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med (2005) 6.13
Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med (2006) 5.90
Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med (2009) 4.27
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med (2006) 4.11
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity (2010) 3.88
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A (2008) 3.12
Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors. Am J Respir Crit Care Med (2011) 2.93
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med (2010) 2.85
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J (2007) 2.76
Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax (2010) 2.60
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med (2008) 2.44
Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med (2002) 2.40
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.21
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A (2002) 2.17
Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation (2003) 2.12
Concealed metastatic lung carcinoma presenting as acute coronary syndrome with progressive conduction abnormalities. Circulation (2012) 2.10
Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.09
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.06
Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 2.02
Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant (2013) 1.71
Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. Am J Respir Crit Care Med (2008) 1.67
Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med (2002) 1.65
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.63
Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression. Chest (2007) 1.62
Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med (2009) 1.59
Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med (2006) 1.58
Rescue treatment in asthma. More than as-needed bronchodilation. Chest (2009) 1.52
Clinical definition of COPD exacerbations and classification of their severity. South Med J (2009) 1.52
Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm. Am J Respir Crit Care Med (2015) 1.52
Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol (2003) 1.51
Acute rejection and graft survival in renal transplanted patients with viral diseases. Mod Pathol (2004) 1.51
Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD. Sarcoidosis Vasc Diffuse Lung Dis (2003) 1.51
Heterotopic cardiac xenotransplantation in rodents: report of a refined technique in a hamster-to-rat model. Microsurgery (2005) 1.47
Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy. Eur J Heart Fail (2009) 1.44
Effect of maternal smoking on breast milk interleukin-1alpha, beta-endorphin, and leptin concentrations and leptin concentrations. Environ Health Perspect (2005) 1.42
Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med (2002) 1.40
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol (2009) 1.40
New targets for drug development in asthma. Lancet (2008) 1.38
Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J (2012) 1.38
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis. J Leukoc Biol (2007) 1.37
The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab (2013) 1.36
Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation (2004) 1.33
Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc (2014) 1.32
IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 1.31
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease. J Pharmacol Exp Ther (2006) 1.29
Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration (2011) 1.28
Hyperforin inhibits cancer invasion and metastasis. Cancer Res (2004) 1.27
2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol (2011) 1.24
Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J Infect Dis (2005) 1.23
Airway inflammation in childhood asthma. Am J Respir Crit Care Med (2003) 1.21
Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit Care Med (2005) 1.19
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J Allergy Clin Immunol (2005) 1.17
Pathophysiology of the small airways in chronic obstructive pulmonary disease. Respiration (2012) 1.16
Retracted Kinase inhibitors and airway inflammation. Eur J Pharmacol (2006) 1.15
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.13
Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study. Thorax (2013) 1.13
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir Res (2005) 1.13
Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management. Cardiovasc Drugs Ther (2015) 1.10
Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. J Allergy Clin Immunol (2007) 1.10
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus. EMBO Mol Med (2012) 1.08
Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis. PLoS One (2011) 1.07
Low-volume ventilation causes peripheral airway injury and increased airway resistance in normal rabbits. J Appl Physiol (1985) (2002) 1.07
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients. Histopathology (2009) 1.06